Stories

The financial results for the Full Year 2024 will be published on February 13, 2025 at 7H00 CET and a conference call will take place at 13H00 CET.

Cholestatic liver diseases are a rare but significant group of conditions that impact both children and adults. Three such conditions—Primary Biliary Cholangitis (PBC), Progressive Familial Intrahepatic Cholestasis (PFIC), and Alagille Syndrome (ALGS)—share commonalities yet are unique in their caus

To close out our ‘A Life in Science’ series, we’re proud to feature Keira Driansky, Executive Vice President and President of North America. Her work exemplifies how collaboration in science – and by staying curious about innovation – can lead to transformative advancements in healthcare. 

In storytelling, you might hear of a superhero who squeezes coal with immense strength and heat, instantly creating a flawless diamond. While fiction, it’s true that diamonds are rare and formed under precise conditions over millions of years. For me, this analogy resonates deeply with the developme

In the latest installment of our ‘A Life in Science’ series, we’re excited to introduce Crystel Ogier, our Clinical Biomarker Director, who leads the awareness and implementation of companion diagnostics at Ipsen. Crystel’s work is a prime example of how cutting-edge science is making a real impact